Global Healthcare Nanotechnology (Nanomedicine) Market Size, Status and Forecast 2020-2026
SKU ID :QYR-15878206 | Published Date: 03-Jul-2020 | No. of pages: 128Description
It is defined as the study of controlling, manipulating and creating systems based on their atomic or molecular specifications. As stated by the US National Science and Technology Council, the essence of nanotechnology is the ability to manipulate matters at atomic, molecular and supra-molecular levels for creation of newer structures and devices. Generally, this science deals with structures sized between 1 to 100 nanometer (nm) in at least one dimension and involves in modulation and fabrication of nanomaterials and nanodevices.
Nanotechnology is becoming a crucial driving force behind innovation in medicine and healthcare, with a range of advances including nanoscale therapeutics, biosensors, implantable devices, drug delivery systems, and imaging technologies.
Market Analysis and Insights: Global Healthcare Nanotechnology (Nanomedicine) Market
The global Healthcare Nanotechnology (Nanomedicine) market size is projected to reach US$ 215130 million by 2026, from US$ 194920 million in 2020, at a CAGR of 9.6%% during 2021-2026.
Global Healthcare Nanotechnology (Nanomedicine) Scope and Market Size
Healthcare Nanotechnology (Nanomedicine) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Healthcare Nanotechnology (Nanomedicine) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
SmitH& Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Takeda
Ipsen
Endo International
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Anticancer
CNS Product
Anti-infective
Other
North America
Europe
China
Japan
Southeast Asia
India
Nanotechnology is becoming a crucial driving force behind innovation in medicine and healthcare, with a range of advances including nanoscale therapeutics, biosensors, implantable devices, drug delivery systems, and imaging technologies.
Market Analysis and Insights: Global Healthcare Nanotechnology (Nanomedicine) Market
The global Healthcare Nanotechnology (Nanomedicine) market size is projected to reach US$ 215130 million by 2026, from US$ 194920 million in 2020, at a CAGR of 9.6%% during 2021-2026.
Global Healthcare Nanotechnology (Nanomedicine) Scope and Market Size
Healthcare Nanotechnology (Nanomedicine) market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Healthcare Nanotechnology (Nanomedicine) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Amgen
Teva Pharmaceuticals
Abbott
UCB
Roche
Celgene
Sanofi
Merck & Co
Biogen
Stryker
Gilead Sciences
Pfizer
3M Company
Johnson & Johnson
SmitH& Nephew
Leadiant Biosciences
Kyowa Hakko Kirin
Takeda
Ipsen
Endo International
Market segment by Type, the product can be split into
Nanomedicine
Nano Medical Devices
Nano Diagnosis
Other
Market segment by Application, split into
Anticancer
CNS Product
Anti-infective
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
TOC
Tables & Figures
Companies
- PRICE
-
$3900$7800$5850Buy Now